Drug Profile
Research programme: modified Salmonella typhimurium - AntiCancer
Alternative Names: A1-RLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator AntiCancer
- Class Bacteria
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone cancer; Breast cancer; Liver cancer; Lung cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bone-cancer in USA (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer in USA (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-cancer in USA (IV)